In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1888 News Items found
Nurse Lauren Kidd smiles while looking at a laptop computer
Fear After Cancer Treatment Is Normal — How Survivors Cope

After completing treatment for cancer, the fear that it will come back is normal — and something that can be managed.
Man in the process of blowing glass at end of a long tube.
Article
How a New Tongue Cancer Treatment Helped an Artist Keep His Voice and His Craft

Learn about a new treatment approach for tongue cancer that allowed a glassblower to continue practicing his art and to find joy in it.
MSK patient Joanne Ferrari-Mautino seen outdoors with her son and boyfriend.
How ROS1-Targeted Therapy Is Helping People With Advanced Lung Cancer Live Better, Longer

Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies.
MSK Chief Scientific Officer Dr. Ross Levine smiles at a trainee in the lab
MSK’s New Chief Scientific Officer, Dr. Ross Levine, on the Future of Cancer Research and Treatment

Learn more about MSK's new Chief Scientific Officer, Dr. Ross Levine, who has dedicated more than 25 years to studying blood and bone marrow cancers: “I believe there has never been a more exciting time for cancer science.”
Dr. Selwyn Vickers stands smiling at a podium
To Our Community

More people are surviving cancer today than at any point in human history — extraordinary progress that fills us with hope. But we also know that “survivorship” brings its own challenges. At MSK, we care for people long after treatment has ended, with programs dedicated to managing the long-term physical and emotional effects of cancer.
Lydia Finley
What Cancer Cells Eat: Cancer Metabolism May Hold Key to New Treatments

Biologist Dr. Lydia Finley studies cell metabolism — how cells convert nutrients into the molecules they need to function — in order to better understand cancer and help develop new treatments.
Two women wearing blue MSK volunteer jackets walk smiling down a hospital hallway.
What Happens After Cancer Treatment Ends? Three Survivors Share Their Stories

Read honest stories about the challenges of survivorship from cancer survivors — and learn how MSK continues to care for people long after treatment has ended.
MSK Medical oncologist and liver cancer specialist Dr. Ghassan K. Abou-Alfa
Article
Liver Cancer Progression Slowed by Adding Immunotherapy to TACE

Read about a new treatment that slows the progression of intermediate-risk liver cancer.
Dr. Eileen O'Reilly seen smiling in an exam room.
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope

Learn how a successful clinical trial for pancreatic cancer in which MSK experts play a leading role is opening a new world of treatment options.
Dr. Alexander Drilon
Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer

A clinical trial led by an MSK researcher found that the targeted therapy selpercatinib reduces the risk of recurrence by more than 80% for patients with early-stage non-small cell lung cancers carrying a RET gene fusion.